Log in to save to my catalogue

Disseminated cytomegalovirus disease after bendamustine: a case report and analysis of circulating B...

Disseminated cytomegalovirus disease after bendamustine: a case report and analysis of circulating B...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_91f7fdf7825c47999231c51955c5506c

Disseminated cytomegalovirus disease after bendamustine: a case report and analysis of circulating B- and T-cell subsets

About this item

Full title

Disseminated cytomegalovirus disease after bendamustine: a case report and analysis of circulating B- and T-cell subsets

Publisher

England: BioMed Central Ltd

Journal title

BMC infectious diseases, 2019-10, Vol.19 (1), p.881-881, Article 881

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Bendamustine, used for the treatment of indolent B-cell non-Hodgkin lymphoma and chronic lymphocytic leukemia, is known to cause prolonged myelosuppression and lymphocytopenia and has been associated with the risk of developing serious and fatal infections. While reports of localized CMV infections in asymptomatic patients exist, disseminated CMV d...

Alternative Titles

Full title

Disseminated cytomegalovirus disease after bendamustine: a case report and analysis of circulating B- and T-cell subsets

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_91f7fdf7825c47999231c51955c5506c

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_91f7fdf7825c47999231c51955c5506c

Other Identifiers

ISSN

1471-2334

E-ISSN

1471-2334

DOI

10.1186/s12879-019-4545-7

How to access this item